Výsledky vyhledávání

A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

Publikováno v: Blood. 91:3509-3517

An observational study was conducted at 18 transplant centers in the United States and Canada to characterize the platelet recovery of patients receiving myeloablative therapy and stem cell transplantation and to determine the clinical variables infl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6df6fcf172c3179d9f1c18b965c99c
https://doi.org/10.1182/blood.v91.9.3509

Zobrazit plný text záznamu

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

Publikováno v: Journal of Clinical Oncology. 15:1870-1879

PURPOSE To identify trends in high-dose therapy with autologous hematopoietic stem-cell support (autotransplants) for breast cancer (1989 to 1995). PATIENTS AND METHODS Analysis of patients who received autotransplants and were reported to the Autolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f382896e3ab3b6be4132285bb62ba296
https://doi.org/10.1200/jco.1997.15.5.1870

Zobrazit plný text záznamu

The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation

Autor: G L, Phillips, J W, Fay, R H, Herzig, H M, Lazarus, S N, Wolff, H S, Lin, D C, Shina, G P, Glasgow, R C, Griffith, C W, Lamb

Publikováno v: Blood. 75:831-838

Intensive chemoradiotherapy, with or without additional local radiotherapy, and unpurged autologous marrow transplantation was given to 68 patients with progressive non-Hodgkin's lymphoma. Responses were attained in 44 patients (65%, 95% confidence i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132926180fad6993802f77cf9e4d2ca1
https://doi.org/10.1182/blood.v75.4.831.bloodjournal754831

Zobrazit plný text záznamu

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Autor: R A, Nash, J H, Antin, C, Karanes, J W, Fay, B R, Avalos, A M, Yeager, D, Przepiorka, S, Davies, F B, Petersen, P, Bartels, D, Buell, W, Fitzsimmons, C, Anasetti, R, Storb, V, Ratanatharathorn

Publikováno v: Blood. 96(6)

After the transplantation of unmodified marrow from human leukocyte antigen-matched unrelated donors receiving cyclosporine (CSP) and methotrexate (MTX), the incidence of acute graft-versus-host disease (GVHD) is greater than 75%. Tacrolimus is a mac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cca6f9122ee75442a2c1cd04eb43cbfb
https://pubmed.ncbi.nlm.nih.gov/10979948

Zobrazit plný text záznamu

Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation

Autor: C S, Chen, K, Seidel, J O, Armitage, J W, Fay, F R, Appelbaum, M M, Horowitz, E J, Shpall, P L, Weiden, K S, Antman, R E, Champlin, J H, Kersey, K M, Sullivan

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 3(6)

Overdoses of high-dose chemotherapy before hematopoietic cell transplantation are serious adverse events, but their frequency and etiology are unknown. The American Society for Blood and Marrow Transplantation (ASBMT) conducted an anonymous national

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::13172cdc4b9016688888f5355a3e002d
https://pubmed.ncbi.nlm.nih.gov/9502301

Zobrazit plný text záznamu

FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors

Autor: R A, Nash, L A, Piñeiro, R, Storb, H J, Deeg, W E, Fitzsimmons, T, Furlong, J A, Hansen, T, Gooley, R M, Maher, P, Martin, P A, McSweeney, K M, Sullivan, C, Anasetti, J W, Fay

Publikováno v: Blood. 88(9)

The safety and potential efficacy of FK506 in combination with a short course of methotrexate (MTX) for the prevention of acute graft-versus-host disease (GVHD) after marrow transplantation from HLA-matched unrelated donors was evaluated in a single-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cf57fb64a7f080201caa8f2a5cf0aae9
https://pubmed.ncbi.nlm.nih.gov/8896434

Zobrazit plný text záznamu

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

Autor: M J, Stone, E A, Sausville, J W, Fay, D, Headlee, R H, Collins, W D, Figg, M, Stetler-Stevenson, V, Jain, E S, Jaffe, D, Solomon, R M, Lush, A, Senderowicz, V, Ghetie, J, Schindler, J W, Uhr, E S, Vitetta

Publikováno v: Blood. 88(4)

IgG-HD37-SMPT-dgA is a deglycosylated ricin A chain (dgA)-containing immunotoxin (IT) prepared by conjugating the monoclonal murine (MoAb) anti-CD19 antibody, HD37, to dgA using the heterobifunctional hindered disulfide linker, N-succinimidyl-oxycarb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5247ee737248fd992eb2647710b96658
https://pubmed.ncbi.nlm.nih.gov/8695836

Zobrazit plný text záznamu

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation

Autor: J W, Fay, J R, Wingard, J H, Antin, R H, Collins, L A, Piñeiro, B R, Blazar, R, Saral, B E, Bierer, D, Przepiorka, W E, Fitzsimmons, R M, Maher, D J, Weisdorf

Publikováno v: Blood. 87(8)

FK506 (Tacrolimus) is an immunosuppressive drug that blocks the activation of antigen-specific T lymphocytes, a major component in the pathogenesis of graft-versus-host disease (GVHD). This study was designed to obtain first estimates of the safety a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2502f801481636e86245eb44d1859cb7
https://pubmed.ncbi.nlm.nih.gov/8605372

Zobrazit plný text záznamu

Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma

Autor: J W, Fay, S H, Bernstein

Publikováno v: Seminars in oncology. 23(2 Suppl 4)

Recombinant human interleukin-3 (rhIL-3), granulocyte-macrophage colony-stimulating factor (rhGM-CSF), and granulocyte colony-stimulating factor (rhG-CSF) enhance neutrophil recovery following autologous bone marrow transplantation (ABMT) for maligna

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::236e44672a5d0dbea6fbf42289a1eda4
https://pubmed.ncbi.nlm.nih.gov/8600545

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání